You have 9 free searches left this month | for more free features.

Condition

Osteogenesis Imperfecta (1)

Osteogenesis Imperfecta Type III (1)

Osteogenesis Imperfecta Type IV (1)

Osteogenesis Imperfecta, Type I (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Ultragenyx Pharmaceutical Inc (2)

Collaborator

Mereo BioPharma (1)

Intervention

setrusumab (2)

bisphosphonate (1)

calcium (1)

vitamin d (1)

zoledronic acid (optional) (1)

Study Documents

Intervention Type

drug (2)

biological (1)

dietary supplement (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

setrusumab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Osteogenesis Imperfecta Trial (Bisphosphonate, Setrusumab)

Not yet recruiting

Osteogenesis Imperfecta

Bisphosphonate
Setrusumab

(no location specified)

Mar 3, 2023

Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III, Osteogenesis Imperfecta Type IV Trial in Worldwide

Completed

Has Results

Osteogenesis Imperfecta, Type I
+2 more

setrusumab
+3 more

Birmingham, Alabama
+24 more

Feb 7, 2022